PHILADELPHIA—High pre-transplant serum phosphorus levels are associated with worse outcomes following renal transplantation, according to study findings presented at Kidney Week 2011.
In a study of 9,384 primary kidney recipients, individuals with pretransplant serum phosphorus levels of 9.5 mg/dL or higher had a 2.4 and 3.6 times increased risk of all-cause and cardiovascular mortality, respectively, compared with patients with levels of at least 3.5 but less than 5.5 mg/dL (reference value), in a fully adjusted model. Patients with serum phosphorus levels of at least 7.5 but less than 9.5 and 9.5 mg/dL or greater had a 1.4 and 2.4 times increased risk of graft loss, respectively.
Marcelo Santos Sampaio, MD, of Harold Simmons Center, Harbor-UCLA Medical Center, Torrance, Calif., and colleagues observed no significant association between pretransplant serum phosphorus levels and delayed graft function.
Enjoying our content?
Thanks for visiting Renal & Urology News. We hope you’re enjoying the latest clinical news, full-length features, case studies, and more.
You’ve viewed {{metering-count}} of {{metering-total}} articles this month. If you wish to read unlimited content, please log in or register below. Registration is free.
{{login-button}} {{register-button}}
Log in to continue reading this article.
Don’t miss out on today’s top content on Renal & Urology News. Register for free and gain unlimited access to:
- Clinical News, with personalized daily picks for you
- Case Studies
- Conference Coverage
- Full-Length Features
- Drug Monographs
- And More
{{login-button}} {{register-button}}
Want to read more?
Please login or register first to view this content.